TY  - JOUR
AU  - Obón-Santacana, Mireia
AU  - Freisling, Heinz
AU  - Peeters, Petra H
AU  - Lujan-Barroso, Leila
AU  - Ferrari, Pietro
AU  - Boutron-Ruault, Marie-Christine
AU  - Mesrine, Sylvie
AU  - Baglietto, Laura
AU  - Turzanski-Fortner, Renee
AU  - Katzke, Verena A
AU  - Boeing, Heiner
AU  - Quirós, J Ramón
AU  - Molina-Portillo, Elena
AU  - Larrañaga, Nerea
AU  - Chirlaque, María-Dolores
AU  - Barricarte, Aurelio
AU  - Khaw, Kay-Tee
AU  - Wareham, Nick
AU  - Travis, Ruth C
AU  - Merritt, Melissa A
AU  - Gunter, Marc J
AU  - Trichopoulou, Antonia
AU  - Lagiou, Pagona
AU  - Naska, Androniki
AU  - Palli, Domenico
AU  - Sieri, Sabina
AU  - Tumino, Rosario
AU  - Fiano, Valentina
AU  - Galassom, Rocco
AU  - Bueno-de-Mesquita, H B As
AU  - Onland-Moret, N Charlotte
AU  - Idahl, Annika
AU  - Lundin, Eva
AU  - Weiderpass, Elisabete
AU  - Vesper, Hubert
AU  - Riboli, Elio
AU  - Duell, Eric J
PY  - 2015
DO  - 10.1002/ijc.29853
UR  - http://hdl.handle.net/10668/10249
T2  - International journal of cancer
AB  - Acrylamide, classified in 1994 by IARC as "probably carcinogenic to humans," was discovered in 2002 in some heat-treated, carbohydrate-rich foods. Four prospective studies have evaluated the association between dietary acrylamide intake and...
LA  - en
KW  - EPIC
KW  - acrylamide
KW  - endometrial cancer
KW  - glycidamide
KW  - hemoglobin adduct
KW  - Acrylamide
KW  - Biomarkers
KW  - Case-Control Studies
KW  - Endometrial Neoplasms
KW  - Epoxy Compounds
KW  - Female
KW  - Hemoglobins
KW  - Humans
KW  - Middle Aged
KW  - Postmenopause
KW  - Prospective Studies
KW  - Risk
TI  - Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort.
TY  - research article
VL  - 138
ER  -